Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier

European Journal of Clinical Investigation

Volumn 32, Issue 5, 2002, Pages 360-371

  Fiala, Milan ^b,e   Liu, Q N ^a   Sayre, J ^d   Pop, V ^a   Brahmandam, V ^a   Graves, M C ^b,e   Vinters, H V ^b,c,e  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Amyloid x beta clearance; Blood brain barrier; HIV 1 encephalitis; Monocyte macrophage; T lymphocyte

Indexed keywords

AMYLOID BETA PROTEIN; CYCLOOXYGENASE 2; ENDOTHELIAL TIGHT JUNCTION PROTEIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ALZHEIMER DISEASE; ANTIGEN RETRIEVAL; ARTICLE; AUTOPSY; B LYMPHOCYTE; BLOOD BRAIN BARRIER; BRAIN TISSUE; CELL INFILTRATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; LYMPHOCYTE; MACROPHAGE; MALE; MICROGLIA; MONOCYTE; NEUROPIL; PHAGOCYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; AIDS DEMENTIA COMPLEX; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BLOOD-BRAIN BARRIER; BRAIN; CEREBROVASCULAR CIRCULATION; CYCLOOXYGENASE 2; HIV-1; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LYMPHOCYTES; MACROPHAGES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PEPTIDE FRAGMENTS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TIGHT JUNCTIONS;

EID: 0037000396     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.00994.x     Document Type: Article

References (71)

1. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21 (3):383-421.
2. Eikelenboom P, Hack CE, Rozemuller JM, Stam FC. Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch B Cell Pathol Incl Mol Pathol 1989;56 (4):259-62.
3. McGeer PL, Akiyama H, Itagaki S, McGeer EG. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci Lett 1989;107 (1-3):341-6.
4. Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, Styren SD et al. Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1992;89 (21):10016-20.
5. Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993;7 (1):75-83.
6. Mrak RE, Griffin WS. Interleukin-1 and the immunogenetics of Alzheimer disease. J Neuropathol Exp Neurol 2000;59 (6):471-6.
7. Strauss S, Bauer J, Ganter U, Jonas U, Berger M, Volk B. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest 1992;66 (2):223-30.
8. van der Wal EA, Gomez-Pinilla F, Cotman CW. Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies. Neuroreport 1993;4 (1):69-72.
9. Xia MQ, Hyman BT. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J Neurovirol 1999;5 (1):32-41.
10. Pasinetti GM, Aisen PS. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 1998;87 (2):319-24.
11. O'Banion MK, Chang JW, Kaplan MD, Yermakova A, Coleman PD. Glial and neuronal expression of cyclooxygenase-2: relevance to Alzheimer's disease. Adv Exp Med Biol 1997;433:177-80.
12. Yasojima K, Schwab C, McGeer EG, McGeer PL. Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs. Brain Res 1999;830 (2):226-36.
13. Ma J, Yee A, Brewer HB Jr, Das S, Potter H. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments [see comments]. Nature 1994;372 (6501):92-4.
14. Selkoe DJ. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann N Y Acad Sci 2000;924:17-25.
15. Cairns NJ, Chadwick A, Luthert PJ, Lantos PL. Astrocytosis, beta A4-protein deposition and paired helical filament formation in Alzheimer's disease. J Neurol Sci 1992;112 (1-2):68-75.
16. Combs CK, Karlo JC, Kao SC, Landreth GE. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 2001;21 (4):1179-88.
17. Tan J, Town T, Paris D, Mori T, Suo Z et al. Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science 1999;286 (5448):2352-5.
18. Haga S, Akai K, Ishii T. Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol (Berl) 1989;77 (6):569-75.
19. Mattiace LA, Davies P, Dickson DW. Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am J Pathol 1990;136 (5):1101-14.
20. Wegiel J, Wang KC, Tarnawski M, Lach B. Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plague degradation. Acta Neuropathol (Berl) 2000;100 (4):356-64.
21. Gitter BD, Boggs LN, May PC, Czilli DL, Carlson CD. Regulation of cytokine secretion and amyloid precursor protein processing by proinflammatory amyloid beta (A beta). Ann N Y Acad Sci 2000;917:154-64.
22. McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 1995;21 (2):195-218.
23. McGeer EG, McGeer PL. The importance of inflammatory mechanisms in Alzheimer disease. Exp Gerontol 1998;33 (5):371-8.
24. Fiala M, Zhang L, Gan X-H, Graves M, Hama S, Crawford F et al. Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model. Mol Med 1998;4:480-9.
25. Gendelman HE, Persidsky Y, Ghorpade A, Limoges J, Stins M, Fiala M et al. The neuropathogenesis of the AIDS dementia complex. AIDS 1997;11 (Suppl. A):S35-45.
26. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233 (4768):1089-93.
27. Glass JD, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995;38 (5):755-62.
28. Wesselingh SL, Power C, Glass JD, Tyor WR, McArthur JC, Farber JM et al. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 1993;33 (6):576-82.
29. Tyor WR, Wesselingh SL, Griffin JW, McArthur JC, Griffin DE. Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9 (4):379-88.
30. Mallat M, Chamak B. Brain macrophages: neurotoxic or neurotrophic effector cells? [see comments]. J Leukoc Biol 1994;56 (3):416-22.
31. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse [see comments]. Nature 1999;400 (6740):173-7.
32. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 2000;6 (8):916-9.
33. Boven LA, Middel J, Portegies P, Verhoef J, Jansen GH, Nottet HS. Overexpression of nerve growth factor and basic fibroblast growth factor in AIDS dementia complex. J Neuroimmunol 1999;97 (1-2):154-62.
34. Smits HA, Boven LA, Pereira CF, Verhoef J, Nottet HS. Role of macrophage activation in the pathogenesis of Alzheimer's disease and human immunodeficiency virus type 1-associated dementia [see comments]. Eur J Clin Invest 2000;30 (6):526-35.
35. Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, Nelson JA et al. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol 1999;155 (6):1915-27.
36. Shi SR, Imam SA, Young L, Cote RJ, Taylor CR. Antigen retrieval immunohistochemistry under the influence of pH using monoclonal antibodies. J Histochem Cytochem 1995;43 (2):193-201.
37. Liu QN, Reddy S, Sayre JW, Pop V, Graves MC, Fiala M. Essential Role of HIV Type 1-Infected and Cyclooxygenase 2-Activated Macrophages and T Cells in HIV Type 1 Myocarditis. AIDS Res Hum Retroviruses 2001;17 (15):1423-33.
38. Dixon WJ. BMDP Statistical Software. Berkeley, CA: University of California Press, 1990.
39. Lawson LJ, Perry VH, Gordon S. Turnover of resident microglia in the normal adult mouse brain. Neuroscience 1992;48 (2):405-15.
40. Gan X, Zhang L, Taub D, Chang S, Stins M, Kim K et al. Cocaine enhances endothelial adhesion molecules and leukocyte migration. Clin Immunol 1999;91:68-76.
41. Dickson DW. The pathogenesis of senile plaques. J Neuropathol Exp Neurol 1997;56 (4):321-39.
42. Glabe C. Does Alzheimer disease tilt the scales of amyloid degradation versus accumulation? [News]. Nat Med 2000;6 (2):133-4.
43. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease [see comments]. Nature 1996;382 (6593):685-91.
44. Mackic JB, Stins M, McComb JG, Calero M, Ghiso J, Kim KS et al. Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1-40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest 1998;102 (4):734-43.
45. Husemann J, Loike JD, Kodama T, Silverstein SC. Scavenger receptor class B type I (SR-BI) mediates adhesion of neonatal murine microglia to fibrillar beta-amyloid. J Neuroimmunol 2001;114 (1-2):142-50.
46. Veld B, Ruitenberg A, Hofman A, Launer L, Duijn C, Stijnen T et al. Nonsteroidal antiiflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 2001;345:1515-21.
47. Yermakova AV, Rollins J, Callahan LM, Rogers J, O'Banion MK. Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons. J Neuropathol Exp Neurol 1999;58 (11):1135-46.
48. Fiala M, Liu QN, Reddy ST, Graves M. Macrophages infiltrate the brain and express COX-2 and iNOS in Alzheimer's disease and AIDS. Alzheimer's Reports 2001;4:1-7.
49. Nottet HS, Persidsky Y, Sasseville VG, Nukuna AN, Bock P, Zhai QH et al. Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J Immunol 1996;156 (3):1284-95.
50. Hickey WF, Vass K, Lassmann H. Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J Neuropathol Exp Neurol 1992;51 (3):246-56.
51. Ling EA, Penney D, Leblond CP. Use of carbon labeling to demonstrate the role of blood monocytes as precursors of the 'ameboid cells' present in the corpus callosum of postnatal rats. J Comp Neurol 1980;193 (3):631-57.
52. Rhodes RH. Evidence of serum-protein leakage across the blood-brain barrier in the acquired immunodeficiency syndrome. J Neuropathol Exp Neurol 1991;50 (2):171-83.
53. Falangola MF, Hanly A, Galvao-Castro B, Petito CK. HIV infection of human choroid plexus: a possible mechanism of viral entry into the CNS. J Neuropathol Exp Neurol 1995;54 (4):497-503.
54. Power C, Kong PA, Crawford TO, Wesselingh S, Glass JD, McArthur JC et al. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 1993;34 (3):339-50.
55. Boven LA, Middel J, Verhoef J, De Groot CJ, Nottet HS. Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV-1-associated dementia [In Process Citation]. Neuropathol Appl Neurobiol 2000;26 (4):356-60.
56. Elovaara I, Icen A, Palo J, Erkinjuntti T. CSF in Alzheimer's disease. Studies on blood-brain barrier function and intrathecal protein synthesis. J Neurol Sci 1985;70 (1):73-80.
57. Hampel H, Kotter HU, Moller HJ. Blood-cerebrospinal fluid barrier dysfunction for high molecular weight proteins in Alzheimer disease and major depression: indication for disease subsets. Alzheimer Dis Assoc Disord 1997;11 (2):78-87.
58. Mattila KM, Pirttila T, Blennow K, Wallin A, Viitanen M, Frey H. Altered blood-brain barrier function in Alzheimer's disease? [see comments]. Acta Neurol Scand 1994;89 (3):192-8.
59. Munoz DG, Erkinjuntti T, Gaytan-Garcia S, Hachinski V. Serum protein leakage in Alzheimer's disease revisited. Ann N Y Acad Sci 1997;826:173-89.
60. Skoog I, Wallin A, Fredman P, Hesse C, Aevarsson O, Karisson I et al. A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia. Neurology 1998;50 (4):966-71.
61. Wada H. Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio. Intern Med 1998;37 (6):509-13.
62. Caserta MT, Caccioppo D, Lapin GD, Ragin A, Groothuis DR. Blood-brain barrier integrity in Alzheimer's disease patients and elderly control subjects. J Neuropsychiatry Clin Neurosci 1998;10 (1):78-84.
63. Stewart PA, Hayakawa K, Akers MA, Vinters HV. A morphometric study of the blood-brain barrier in Alzheimer's disease. Lab Invest 1992;67 (6):734-42.
64. Singer EJ, Syndulko K, Fahy-Chandon B, Schmid P, Conrad A, Tourtellotte WW. Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease. J Acquired Immune Deficiency Syndromes 1994;7 (3):265-71.
65. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 1992;176 (6):1703-18.
66. Nath A, Geiger J. Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog Neurobiol 1998;54 (1):19-33.
67. Webster SD, Yang AJ, Margol L, Garzon-Rodriguez W, Glabe CG, Tenner AJ. Complement component C1q modulates the phagocytosis of Abeta by microglia. Exp Neurol 2000;161 (1):127-38.
68. Frautschy SA, Yang F, Irrizarry M, Hyman B, Saido TC, Hsiao K et al. Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol 1998;152 (1):307-17.
69. Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J Neurosci 1996;16 (18):5795-811.
70. Giri R, Shen Y, Stins M, Du Yan S, Schmidt AM, Stern D et al. beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1 [In Process Citation]. Am J Physiol Cell Physiol 2000;279 (6):C1772-81.
71. Anders KH, Wang ZZ, Kornfeld M, Gray F, Soontornniyomkij V, Reed LA et al. Giant cell arteritis in association with cerebral amyloid angiopathy: immunohistochemical and molecular studies. Hum Pathol 1997;28 (11):1237-46.